Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer
| Image |  |
|---|---|
| Description | scientific article published on 15 July 2017 |
| Author/s |
author: Nicola Curtin Richard Edmondson John Lunec |
| Publication date | July 15, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |